Bal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.
01 3Bal Pharma
02 4Aeon
03 5Aurobindo Pharma Limited
04 6Biofarma Pharmaceutical Industry and Commerce Inc
05 2Dorsa Darou Pharmaceutical Company
06 2Ind Swift Laboratories Limited
07 6Indoco Remedies Limited
08 3Intas Pharmaceuticals
09 2Ipca Laboratories Limited
10 1Jeil Pharmaceutical Co., Ltd.
11 1Kolmar Korea Co., Ltd.
12 2Lucent Biotech Ltd
13 2Madras Pharmaceuticals
14 4TECNIMEDE
15 1Theon Pharmaceuticals
16 4Torrent Pharmaceuticals Limited
17 2Vaishali Pharma Ltd
18 2XL Laboratories Private Limited
19 5Zota Healthcare Ltd
01 6ALOGLIPTIN BENZOATE; Pioglitazone
02 2Glimepiride; Pioglitazone; Metformin
03 1Metformin Hydrochloride; Pioglitazone
04 1Metformin; Pioglitazone
05 42Pioglitazone
06 5Pioglitazone; Metformin
01 2ER TABLET
02 1Film Coated Tablet
03 12TABLET
04 2TABLETS
05 40Tablet
01 112.5MG; 15MG
02 112.5MG; 30MG
03 112.5MG; 45MG
04 1715MG
05 215MG; 500MG
06 415MG; 850MG
07 11MG; 15MG; 500MG
08 125MG; 15MG
09 125MG; 30MG
10 125MG; 45MG
11 12MG; 15MG; 500MG
12 1730MG
13 745MG
14 1500MG; 15MG
15 17.5MG
01 43India
02 2Iran
03 4Portugal
04 2South Korea
05 6Turkey
Bal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.
Regulatory Info : Generic
Registration Country : India
Metformin Hydrochloride; Pioglitazone
Brand Name : Piorest M
Dosage Form : Tablet
Dosage Strength : 500MG; 15MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Bal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.
Packaging :
Regulatory Info : Generic
Metformin Hydrochloride; Pioglitazone
Dosage : Tablet
Dosage Strength : 500MG; 15MG
Brand Name : Piorest M
Approval Date :
Application Number :
Registration Country : India
Bal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.
Regulatory Info :
Registration Country : India
Brand Name : Piorest
Dosage Form : Tablet
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Bal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 15MG
Brand Name : Piorest
Approval Date :
Application Number :
Registration Country : India
Bal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.
Regulatory Info :
Registration Country : India
Brand Name : Piorest
Dosage Form : Tablet
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Bal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 30MG
Brand Name : Piorest
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : TABLET
Dosage Strength : 7.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Dosage : TABLET
Dosage Strength : 7.5MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : TABLET
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Dosage : TABLET
Dosage Strength : 15MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : TABLET
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Dosage : TABLET
Dosage Strength : 30MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : TABLET
Dosage Strength : 45MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Dosage : TABLET
Dosage Strength : 45MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name : Glitter 15
Dosage Form : TABLET
Dosage Strength : 15MG
Packaging : 10x1x10 Blisters
Approval Date :
Application Number : 78670
Regulatory Info : Generic
Registration Country : India
Packaging : 10x1x10 Blisters
Regulatory Info : Generic
Dosage : TABLET
Dosage Strength : 15MG
Brand Name : Glitter 15
Approval Date :
Application Number : 78670
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name : Glitter 30
Dosage Form : TABLET
Dosage Strength : 30MG
Packaging : 10x1x10 Blisters
Approval Date :
Application Number : 21925
Regulatory Info : Generic
Registration Country : India
Packaging : 10x1x10 Blisters
Regulatory Info : Generic
Dosage : TABLET
Dosage Strength : 30MG
Brand Name : Glitter 30
Approval Date :
Application Number : 21925
Registration Country : India
Regulatory Info : Generic
Registration Country : India
ALOGLIPTIN BENZOATE; Pioglitazone
Brand Name :
Dosage Form : Tablet
Dosage Strength : 25MG; 15MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
ALOGLIPTIN BENZOATE; Pioglitazone
Dosage : Tablet
Dosage Strength : 25MG; 15MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : TABLETS
Dosage Strength : 15MG
Packaging : 10x10's, 3x10's
Approval Date :
Application Number : 78670
Regulatory Info : Generic
Registration Country : India
Packaging : 10x10's, 3x10's
Regulatory Info : Generic
Dosage : TABLETS
Dosage Strength : 15MG
Brand Name :
Approval Date :
Application Number : 78670
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : TABLETS
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number : 21925
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Dosage : TABLETS
Dosage Strength : 30MG
Brand Name :
Approval Date :
Application Number : 21925
Registration Country : India
Regulatory Info : Generic
Registration Country : South Korea
Brand Name :
Dosage Form : TABLET
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Korea
Packaging :
Regulatory Info : Generic
Dosage : TABLET
Dosage Strength : 15MG
Brand Name :
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info : Generic
Registration Country : India
Brand Name : GLIZAT
Dosage Form : TABLET
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number : 78670
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Dosage : TABLET
Dosage Strength : 15MG
Brand Name : GLIZAT
Approval Date :
Application Number : 78670
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name : GLIZAT
Dosage Form : TABLET
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number : 21925
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Dosage : TABLET
Dosage Strength : 30MG
Brand Name : GLIZAT
Approval Date :
Application Number : 21925
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : TABLET
Dosage Strength : 15MG; 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Dosage : TABLET
Dosage Strength : 15MG; 500MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : TABLET
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Dosage : TABLET
Dosage Strength : 15MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : TABLET
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Dosage : TABLET
Dosage Strength : 30MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Glimepiride; Pioglitazone; Metformin
Brand Name :
Dosage Form : ER TABLET
Dosage Strength : 1MG; 15MG; 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Glimepiride; Pioglitazone; Metformin
Dosage : ER TABLET
Dosage Strength : 1MG; 15MG; 500MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Glimepiride; Pioglitazone; Metformin
Brand Name :
Dosage Form : ER TABLET
Dosage Strength : 2MG; 15MG; 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Glimepiride; Pioglitazone; Metformin
Dosage : ER TABLET
Dosage Strength : 2MG; 15MG; 500MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
